. The highest hereditary fractions at individual tumour sites were seen for: retinoblastoma (37.2%); kidney (7.2%); leukaemia (2.6%) and brain and spinal cord (2.0%). When information about family history from published reports was incorporated into the figures calculated from Registry data the total genetic fraction was estimated to be 4.2%. We conclude that there is a clear genetic basis for a small minority of the cancers of childhood, but ethnic variation and the lack of known environmental determinants suggest that the total influence of heredity may be higher.
A subgroup of cases of childhood cancer are due to inherited genetic mutations -either transmitted from a carrier parent or arising de novo in a parental germ cell. On occasion such mutations are detectable by cytogenetic examination, but for the great majority, the hereditary nature of cancer is inferred from inspection of the patient's pedigree or from some unusual feature of the clinical presentation. The child's family may carry a predisposing genetic trait (e.g. neurofibromatosis or ataxia-telangiectasia) or may reveal an excess number of cancers in a Mendelian pattern. It has been suggested that the presence of bilateral tumours in childhood indicates genetic susceptibility (Knudson et al., 1973) , a hypothesis confirmed for retinoblastoma by the rate of appearance of these tumours in offspring. The association in a child of a cancer and particular congenital malformations, most notably aniridia or hemihypertrophy, may signal the presence of an underlying mutation.
Current theory proposes that a sequence of genetic mutations leads to the formation of a cancer cell with the capacity for uncontrolled growth. Should one or more of the mutations in the sequence be present at conception, or should an individual be liable to an elevated rate of chromosome breakage or lack an effective DNA repair mechanism, the risk of cancer is likely to be elevated. If such a trait is shared by several members of a pedigree, familial clustering may occur.
Non-genetic explanations for the appearance of multiple tumours in a family include exposure to a common environmental hazard and chance. An individual treated for an initial tumour may be at high risk for a second because of innate susceptibility or because of the mutagenic effects of anti-neoplastic treatment.
Harmful aspects of the environment have been implicated as causing perhaps 70% of all cancer (Doll & Peto, 1981) but because of the lesser variability in incidence seen from country to country for the common neoplasms of childhood (Parkin et al., 1988) , and because familial cancers tend to appear at younger ages than isolated cases, it is reasonable to inquire whether heredity plays a primary role in the etiology of cancer in children. We have reviewed all cases of cancer reported to the population-based National Registry of Childhood Tumours in Great Britain for a 13-year period in an attempt to estimate the proportion of childhood cancer due (Draper et al., 1988; Stiller et al., 1988) .
Cases considered to have a hereditary basis include: (1) all bilateral retinoblastomas and Wilms' tumours; (2) all children for which an established underlying genetic condition had been recorded; and (3) all tumours occurring in children with aniridia or hemihypertrophy. Excluded were cases with a history of a congenital malformation not specifically known to be associated with a defined genetic syndrome.
Information about family history was not routinely available, but was provided for some tumour types, including medullary carcinoma of the thyroid. Genetic cancer syndromes diagnosed on the basis of multiple primary tumours or the appearance of a subsequent benign manifestation of the syndrome will often be missed in the present analysis.
The relative risk for developing cancer was calculated by dividing the observed number of hereditary cancer cases by the expected number. The expected number was the product of the prevalence of the genetic condition taken from published reports and the total number of tumour registrations. The (two-sided) P-values and confidence limits associated with risk estimates were calculated assuming a Poisson distribution of the observed number of cases.
Results
Of the total number of tumours reported, 509 or 3.07% had an underlying genetic condition recorded, the frequencies of which appear in Table I Tuberous sclerosis is estimated to affect one in 15,000 children in Great Britain (Hunt & Lindenbaum, 1987) . The relative risk of 18.1 for all types of cancer in these children (95% CI, 11.1 to 28.0) could be accounted for by a 70-fold increase in brain tumours and 50-fold risk for rhabdomyosarcoma (Table IV 16.3b Expected numbers of tumours based on an incidence of neurofibromatosis of 1:3000 individuals (Crowe et al., 1956 ). Because of the high proportions of optic gliomas, pheochromocytoma, meningiomas and neurofibrosarcomas associated with neurofibromatosis the odds ratio is used to approximate the relative risk. ap<0.05; bp <0.001 Less than 3% of the genetic cancers were attributable to immunodeficiency (Table V) . The risk for lymphoma among children with ataxia-telangiectasia, based on a disease frequency of one in 100,000 (Pippard et al., 1988) was 400 times greater than in the general population. One child with skin carcinoma and IgA deficiency was reported. (Table VI) . This estimate is larger than the figure of 40% often quoted, and the 44% figure from the earlier Registry report (Draper et al., 1986) (Hartley et al., 1986) . Barring chance association, four of the tumours may be attributed to a variant of the Li-Fraumeni syndrome. These proportions need to be confirmed in other populations. Osteosarcomas also appear in families with hereditary retinoblastoma, either as second primary tumours or in individuals without prior disease. In a British study 6 .0% of survivors of hereditary retinoblastoma had developed an osteosarcoma within 18 years of the original diagnosis (Draper et al., 1986) .
Childhood adrenocortical carcinomas appear in families at high risk for various neoplasms, including rhabdomyosarcoma, brain tumours, breast cancer, and osteosarcoma (Miller, 1978) and are often followed by tumours at other sites (Fraumeni, 1977; Levine 1978 Estimates with decimals incorporate information from published reports (see text). Integer estimates are based on National Childhood Tumour Registry data only. The tumours associated with the Li-Fraumeni syndrome in the epithelial category are adrenocortical carcinomas. No overlap is assumed between the three subgroups ofunilateral retinoblastoma. The estimated number ofbone tumours following retinoblastoma is based on the derived mean of the incidence at 12 years (3.6%) and at 18 years (6.0%) post-treatment, from Draper et al., 1986 . age 14. In another child, an osteosarcoma developed 10 years after the initial diagnosis at age two. Two of these children have been reported previously (Hartley et al., 1987 (Hors et al., 1985) and favours a multifactorial pattern of inheritance. Siblings of Hodgkin's disease patients have an increased risk 7-fold (Grufferman et al., 1977) or greater (Hafez et al., 1985a) , but because of the rarity of Hodgkin's disease the size of the actual increase is small and risks are not specifically calculated for children. Acute leukaemia in siblings has also been documented (Miller, 1963 (Knudson & Strong, 1972) and one of 246 children with neuroblastoma registered in Denmark from 1943-1980 had a positive family history (Carlsen, 1986) . In other studies familial cases were not seen (Kramer et al., 1987) . The total hereditary fraction of neuroblastoma is probably less than 1%. None of a total of 48 children of apparently sporadic cases developed neuroblastoma in three follow-up series (Li & Jaffe 1974; Bundey & Evans 1982; Hawkins et al., 1989) .
Although family history is an established risk factor for adult testicular tumours (Dieckmann et al., 1987) , there is little evidence for a familial predisposition in children. In a recent review of 82 reported family occurrences the only childhood tumours were two seminomas in brothers aged 13 and 14 (Dieckmann et al., 1987) . Seminomas figured in 66 of the 82 affected first degree relative pairs, but this subtype represents only two per cent of childhood testicular cancer (Li & Fraumeni, 1972) . More common childhood forms include embryonal carcinoma and teratocarcinoma (Exelby, 1980) . In an American hospital-based series, none of 70 children with testicular tumours had a positive family history noted in the chart (Li & Fraumeni, 1972) . None of the testicular tumours in the Registry were bilateral.
Malignant melanoma may cluster in families, and perhaps 10% of cases are the expression of the dysplastic nevus syndrome (Greene et al., 1983) . As younger cases are more likely to be familial, it is surprising that none of the 78 children reported by Bader et al. (1985) or 27 children presenting with malignant melanoma in St Judes Hospital, Boston had affected relatives (Pratt et al., 1988 This figure is similar to the Registry figure (2.3%) and to others (Stewart et al., 1958; Kardos et al., 1983) but is greater than the 1.1% observed in surveys in Boston 1947 --1965 (Fraumeni et al., 1971 ) and Manchester 1954 -1968 (Evans & Steward, 1972 . The increase may reflect improved survival of children with Down syndrome, recently estimated to be 76.6% to age 15 in British Columbia (Baird & Sadovnick, 1989) , as compared with 48% survival to age 3 at the time of the Manchester survey (Evans & Steward, 1972) .
Although the finding of a single case of malignant testicular teratoma in a 14 year-old boy with Down syndrome is not statistically significant, it confirms other reports (Miller, 1970; Dexeus et al., 1988; Baird & Sadovnick, 1988) , including that of Mann et al. (1989) who found two children with Down syndrome among 61 cases of childhood testicular tumours when 0.07 cases were expected (P<0.01).
The malignant complications of neurofibromatosis are well known (Hope & Mulvihill, 1981) . Of a total of 401 children hospitalised with neurofibromatosis in the five series summarised by Hope & Mulvihill (1981) and more recently (Blatt et al., 1986) Congenital immunodeficiencies which predispose to lymphoma and leukaemia in children include ataxia-telangiectasia, the Wiskott-Aldrich syndrome, the Chediak-Higashi syndrome, congenital agamaglobulinemia and the X-linked lymphoproliferative syndrome (Filipovich et al., 1985; Purtilo et al., 1975) . Thirteen per cent of children with the recessive degenerative disease ataxia-telangiectasia, which has an incidence of one in 100,000 (Pippard et al., 1988) , will develop cancer by age 15 (60% of these are lymphomas and 27% leukaemia) (Morrel et al., 1986) . Fifty per cent of the cases of leukaemia reported to the Immunodeficiency Cancer Registry from 1973-1984 were associated with to ataxia-telangiectasia (Filipovich et al., 1985) but ages of diagnosis were not given. Ataxia-telangiectasia was not associated with childhood leukaemia in the present study.
The reasons for the documented association of congenital defects and several cancers are not clear. In rare cases a prenatal exposure has been implicated (e.g. diethylstilbesterol, genital malformations and vaginal adenocarcinomas; Herbst et al., 1975 (King-ston et al., 1983; Li et al., 1987) . Defects of the neural tube, sacrum and pelvis are more common in children with germ cell tumours (Fraumeni et al., 1973; Birch et al., 1982) . If genetic counselling is to be applied to the prevention of cancer, it is first necessary to identify the individual at riskbut a positive family history will be seen in only a fraction of genetic cases. The vast majority of occurrences of Down syndrome are sporadic. Three quarters of patients with genetic retinoblastoma (Bunin et al., 1989; Sanders et al., 1988) and 89% of bilateral Wilms' tumour patients (Breslow et al., 1988) occur in families with no other members affected. One-half of neurofibromatosis cases are the result of new mutations (Crowe et al., 1956 ) and as average family size becomes smaller, the majority of new cases of recessive disease will be isolated as well.
The diagnosis of a few cancer syndromes is now possible by polymorphic DNA markers, including retinoblastoma (Wiggs et al., 1988) and multiple endocrine neoplasia (type 2a (Sobol et al., 1989) ) or direct analysis of mutations (Yandell et al., 1989) and early identification and surgery may benefit the individual at-risk. Prophylactic surgery is also advised for the rare female patient with gonadal dysgenesis who carries Y chromosome material. Although the recurrence risk in neuroblastoma has not been precisely established, screening of close relatives of cases by urinary catecholamines is probably justified.
The results of this survey and literature review suggest that roughly 4% of childhood cancers are directly attributable to genetic conditions. Because an underlying syndrome or a positive family history may be unrecognised or go unreported, this estimate is likely to be a minimum. Variations in incidence between ethnic groups for several tumour types and a lack of known environmental determinants suggest that the role of hereditary factors in childhood cancer may be considerably greater. 
